drugset / Trial / NCT01050829

Gadobutrol Magnevist-controlled Body Study

NCT01050829

Phase 3 Completed 370 enrolled Bayer
RandomizedParallel-groupSingle-blindDiagnostic

Summary

The purpose of the study is to look at the safety (what are the side effects) and efficacy (how well does it work) of gadobutrol when used for taking MR images of the body/extremities regions. The results of the MRI with gadobutrol injection will be compared to the results of MR images taken without contrast and with the results of the MR images taken with Magnevist.

Timeline

Start
2010-01
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadobutrol Diagnostic / imaging agent 0.1 unknown
Comparator Gadopentetate dimeglumine Diagnostic / imaging agent 0.1 unknown

Indications

No indication recorded.